OREANDA-NEWS.Trinity Biotech plc (NasdaqGS: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, March 3, 2015. The Company has scheduled a conference call for that same day, Tuesday, March 3, 2015 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

            USA:                  1-866-652-5200

            International:      1-412-317-6060

            Conference ID #: 10061470

A simultaneous webcast of the call can be accessed at:

http://www.videonewswire.com/event.asp?id=101700

A replay of the call can be accessed until March 9, 2015 by dialing:

            USA:                  1-877-344-7529

            International:      1-412-317-0088

            Conference ID #: 10061470

The webcast of the call will be available for 30 days at:

http://www.videonewswire.com/event.asp?id=101700

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.